22 results on '"Zou, Huachun"'
Search Results
2. Correlates of sexual and reproductive health service utilization among older adults in China: Findings from the sexual well-being (SWELL) study
- Author
-
Peng, Xin, Wang, Bingyi, Li, Xinyi, Li, Yuwei, Lu, Yong, Liu, Jiewei, Ouyang, Lin, Wu, Guohui, Cai, Yong, Yu, Maohe, Tucker, Joseph D., Tang, Weiming, Wu, Dan, Meng, Xiaojun, and Zou, Huachun
- Published
- 2024
- Full Text
- View/download PDF
3. Loneliness and its correlates among older adults living with HIV: A multicenter cross-sectional study
- Author
-
Wang, Bingyi, Peng, Xin, Liang, Bowen, Fu, Leiwen, Shi, Tongxin, Li, Xinyi, Tian, Tian, Xiao, Xin, Wang, Ying, Ouyang, Lin, Cai, Yong, Yu, Maohe, Wu, Guohui, Li, Linghua, Meng, Xiaojun, and Zou, Huachun
- Published
- 2023
- Full Text
- View/download PDF
4. Associations between COVID-19 related stigma and sleep quality among COVID-19 survivors six months after hospital discharge
- Author
-
Fu, Leiwen, Wang, Bingyi, Chan, Paul Shing Fong, Luo, Dan, Zheng, Weiran, Ju, Niu, Hu, Yuqing, Xiao, Xin, Xu, Hui, Yang, Xue, Fang, Yuan, Xu, Zhijie, Chen, Ping, He, Jiaoling, Zhu, Hongqiong, Tang, Huiwen, Huang, Dixi, Hong, Zhongsi, Ma, Xiaojun, Hao, Yanrong, Cai, Lianying, Yang, Jianrong, Yuan, Jianhui, Chen, Yao-Qing, Xiao, Fei, Wang, Zixin, Ye, Shupei, and Zou, Huachun
- Published
- 2022
- Full Text
- View/download PDF
5. Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings
- Author
-
Chen, Cheng-Pin, Cheng, Chien-Yu, Zou, Huachun, Cheng, Chun-Han, Cheng, Shu-Hsing, Chen, Cheng-Kuo, Chen, Ching-Hsiang, and Bair, Ming-Jong
- Published
- 2019
- Full Text
- View/download PDF
6. Trends and predictions of tuberculosis notification in mainland China during and after the COVID-19 pandemic.
- Author
-
Liu, Yueting, Sun, Ruoyao, Zhang, Hongyin, Huang, Jinrong, Chen, Meiru, Zhan, Yiqiang, Xiang, Jianbang, Yuan, Jianhui, Zou, Huachun, Martinez, Leonardo, and Yang, Chongguang
- Published
- 2023
- Full Text
- View/download PDF
7. Perceptions and worries about monkeypox, and attitudes towards monkeypox vaccination among medical workers in China: A cross-sectional survey.
- Author
-
Peng, Xin, Wang, Bingyi, Li, Yuwei, Chen, Yuanyi, Wu, Xinsheng, Fu, Leiwen, Sun, Yinghui, Liu, Qi, Lin, Yi-Fan, Liang, Bingyu, Fan, Yinguang, and Zou, Huachun
- Abstract
The World Health Organization (WHO) declared monkeypox a "public health emergency of international concern" on 23 June 2022. However, there is a lack of data on monkeypox perceptions among medical workers. The purposes of this study were to evaluate perceptions, worries about monkeypox, attitudes towards monkeypox vaccination and their correlates among medical workers in China. Data were collected from medical practitioners using an online survey questionnaire between September 1 and September 30, 2022 in China. All the subjects completed an online questionnaire including general characteristics, perceptions/knowledge/worries about monkeypox, and attitudes towards monkeypox vaccination. Logistic regression was employed to examine the correlates of perceptions, worries about monkeypox, and attitudes toward monkeypox vaccination. In total, this study sample included 639 medical workers. The mean age was 37.9 ± 9.4 years old. Approximately 71.8% of individuals reported perceptions of monkeypox, 56.7% worried about monkeypox, and 64.9% supported the promotion of monkeypox vaccination. Medical workers who were older than 50 years (aOR 3.73, 95%CI 1.01–13.85), worked in the Infectious Diseases/Dermatology/Venereal Diseases departments (3.09, 1.61–5.91), and provided correct answer to monkeypox transmission route (10.19, 5.42–19.17) were more likely to know about monkeypox/monkeypox virus before investigation. 30.7% reported that they were more worried about monkeypox than the coronavirus (COVID-19). Participants reported that the key population most in need of monkeypox vaccination were health practitioners (78.2%) and people with immunodeficiency (74.3%), followed by children (65.4%) and older adults (63.2%). Awareness of monkeypox was high and attitude towards the promotion of monkeypox vaccination was positive among medical staff in China. Further targeted dissemination of monkeypox common knowledge among health care providers might improve their precaution measures and improve the promotion of monkeypox vaccination among key populations. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Perceptions, precautions, and vaccine acceptance related to monkeypox in the public in China: A cross-sectional survey.
- Author
-
Wang, Bingyi, Peng, Xin, Li, Yuwei, Fu, Leiwen, Tian, Tian, Liang, Bingyu, Sun, Yinghui, Chen, Yuanyi, Wu, Xinsheng, Liu, Qi, Lin, Yi-Fan, Meng, Xiaojun, and Zou, Huachun
- Abstract
The World Health Organization declared monkeypox as a Public Health Emergency of International Concern. A cross-sectional online survey was conducted to understand beliefs, attitudes, perceived preventive measures, and vaccination acceptance related to monkeypox in the public in China. Between August 30 and September 15, 2022, we recruited adults through an online survey platform. Demographic characteristics, perceptions, common knowledge, concerns, attitudes, willingness to adopt preventive measures (including hygiene practices, social distancing, and travel avoidance), and vaccination acceptance related to monkeypox were collected. Logistic regression was used to assess correlates of concerns about monkeypox, willingness to adopt preventive measures, and vaccination acceptance. 2135 participants were recruited (median age: 31.4 years). 62.7% were concerned about monkeypox. 33.2% were more concerned about monkeypox compared to COVID-19. Males (aOR 0.61, 95%CI 0.50–0.74), accessing monkeypox information from the Internet (0.77, 0.61–0.98), and willingness to adopt monkeypox vaccine (2.9, 2.38–3.53) were associated with concerns about monkeypox. Most participants were willing to adopt precautions (76.3% hygiene practices, 68.2% social distancing, 85.9% travel avoidance). Individuals who were concerned about monkeypox (hygiene practices: 2.09, 1.69–2.59; social distancing: 1.78, 1.46–2.16; travel avoidance: 1.74, 1.34–2.26) and had better knowledge about monkeypox (hygiene practices: 1.85, 1.48–2.31; social distancing: 2.17, 1.77–2.66; travel avoidance: 1.74, 1.34–2.26) were more likely to adopt precautions. 68.8% were willing to adopt monkeypox vaccine. Participants with older age (aged 40–49: 0.57, 0.38–0.85; aged 50 +: 0.50, 0.31–0.81), and higher income (¥6000–10,000: 0.61, 0.39–0.95; ≥¥10,000: 0.48, 0.30–0.77) were less likely to adopt the monkeypox vaccine. Being concerned more about monkeypox compared to COVID-19 (1.63, 1.31–2.02), and having better knowledge about monkeypox (1.34, 1.09–1.66) were associated with willingness to adopt vaccination. Compared with COVID-19, monkeypox attracted significantly less attention in the public in China, who currently have insufficient monkeypox knowledge. Interventions aimed at improving monkeypox knowledge and precautions among different groups of individuals in China are needed. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007–2018: A retrospective cohort study.
- Author
-
Li, Meijuan, Liu, Tingyan, Luo, Ganfeng, Sun, Xiaoli, Hu, Guiying, Lu, Ying, H Xu, Richie, Zou, Huachun, and Luo, Xiping
- Abstract
Previous studies showed the incidence, persistence and clearance of cervical human papillomavirus (HPV) among women varies from regions. There is no study on dynamic changes of HPV infection among women in Guangdong. It is a retrospective cohort study that included gynecological outpatients aged ≥15 years and retested for HPV within 24 months in Guangdong Women and Children Hospital to estimate HPV incidence, persistence and clearance. Outcomes were estimated through the proportion of HPV incidence, persistence and clearance in HPV-negative or HPV-positive women. Moreover, we examined HPV incidence, persistence and clearance among women who retested in four calendar periods: 0–6, 6–12, 12–18, 18–24 months after the first test. 33,328 gynecological outpatients were included in our study. Incidence rates of any HPV, high-risk (HR) HPV and low-risk (LR) HPV were 10.58%, 8.68% and 4.83%. The most common incident HR HPV were HPV52 (2.69%), HPV16 (1.23%) and HPV58 (1.23%). Persistence rates of any HPV, HR HPV and LR HPV were 47.55%, 42.77% and 33.88%. HPV52 (42.33%), HPV58 (40.74%) and HPV68 (32.36%) were commonly found persistent types. And clearance rates of any HPV, HR HPV and LR HPV were 52.44%, 57.23% and 66.12%.The lowest clearance rates were observed for HPV52 (57.67%), HPV68 (67.64%) and HPV39 (68.56%). HPV incidence and persistence were higher among women aged 15–19 years and ≥55 years. HPV incidence and persistence were found higher among women who retested within 6 months than others in other periods. HPV52, 58, 68, and 39 were the more likely to cause incident and persistent infection, and less likely to be cleared among women in Guangdong. HPV incidence and persistent infection were higher among women aged both younger and older women compared to middle aged women. HPV retesting period may impact the detection of HPV incidence, persistence and clearance. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Interviews to better understand the burden of mental health disease among COVID-19 survivors: Things to consider
- Author
-
Wang, Bingyi, Fu, Leiwen, Ju, Niu, Xiao, Xin, and Zou, Huachun
- Published
- 2021
- Full Text
- View/download PDF
11. Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection?
- Author
-
Leng, Xinying, Zou, Huachun, Zhang, Kechun, Chen, Yaqi, and Ke, Wujian
- Subjects
- *
MYCOPLASMA , *MYCOPLASMA diseases , *GENETIC mutation , *ENZYMES , *QUINOLONE antibacterial agents , *DRUG resistance in microorganisms , *MACROLIDE antibiotics , *ANTIBIOTICS - Published
- 2022
- Full Text
- View/download PDF
12. Learning about HIV the hard way: HIV among Chinese MSM attending university.
- Author
-
Zou, Huachun, Tucker, Joseph D, Fan, Song, Xu, Junjie, Yu, Maohe, Luo, Zhenzhou, Cai, Weiping, and Grulich, Andrew E
- Subjects
- *
HIV infection transmission , *PREVENTION of infectious disease transmission , *HIV infection epidemiology , *HEALTH attitudes , *HEALTH education , *HOMOSEXUALITY , *PREVENTIVE health services , *RESEARCH funding , *STUDENTS , *UNIVERSITIES & colleges , *DISEASE incidence - Published
- 2018
- Full Text
- View/download PDF
13. Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study.
- Author
-
Zou, Huachun, Tabrizi, Sepehr N, Grulich, Andrew E, Hocking, Jane S, Bradshaw, Catriona S, Cornall, Alyssa M, Morrow, Andrea, Prestage, Garrett, Law, Matthew G, Garland, Suzanne M, Chen, Marcus Y, and Fairley, Christopher K
- Subjects
- *
TRANSMISSION of papillomavirus diseases , *GAY people , *DNA , *DISEASE prevalence , *CLINICAL trials - Abstract
Summary Background Men who have sex with men (MSM) have an increased risk of anogenital human papilomavirus (HPV) infection, which can lead to HPV-related anogenital lesions such as warts, anal intraepithelial neoplasia, and anal cancer. Some of these HPV types are preventable with vaccines. We aimed to describe the incidence of anal, penile, and oral HPV infection, and to estimate the site-specific transmission probability per partner, for teenage MSM. Methods In our observational cohort study, we enrolled teenage MSM (aged 16–20 years) with low sexual exposure and a low prevalence of HPV in Melbourne (VIC, Australia). At baseline, 3, 6, and 12 months, we took a swab from the anal canal, and participants self-collected a swab from the penis and an oral rinse. Our primary outcome was definite and probable incident HPV infection of the anus, penis, or mouth at any time in the 12 months from baseline, assessed through the presence of HPV DNA. We defined definite incident HPV infection as the same HPV type detected more than once from the same site in men who had a negative HPV test at baseline. We defined probable incident HPV infection as only one positive test. We estimated the probability of HPV transmission per partner using HPV prevalence in MSM with a similar age to partners of men in our cohort. This study is registered at the Australian New Zealand Clinical Trials Registry and ClinicalTrials.gov , numbers ACTRN12611000857909 and NCT01422356 . Findings We enrolled 200 MSM aged 16–20 years (median 19 years [IRQ 18–20; range 16–20]) between Sept 20, 2010, and Aug 24, 2012. Over the 12 month follow-up period, we detected 48 definite (107 possible) HPV infections in the anus, ten definite (34 possible) HPV infections on the penis, and no definite (six possible) infections in the mouth. Definite incidence rate per 100 person-years for any anal HPV infection was 57 (95% CI 46–68), and for any anal HPV type in the quadrivalent vaccine was 33 (23–44). Definite incidence rate per 100 person-years for any penile HPV was 12 (6–21) and for any HPV type in the quadrivalent vaccine was 5 (1–12). Estimated probabilities of HPV transmission from the penis to the anus were significantly higher than were those from the anus to the penis (p<0·05 for all HPV types in the quadrivalent vaccine). Interpretation High incidence rates suggest that the vaccination coverage in MSM will need to be high. The transmission estimates will inform HPV modelling. Funding Merck. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Sexual Behaviors and Risk for Sexually Transmitted Infections Among Teenage Men Who Have Sex With Men.
- Author
-
Zou, Huachun, Prestage, Garrett, Fairley, Christopher K., Grulich, Andrew E., Garland, Suzanne M., Hocking, Jane S., Bradshaw, Catriona S., Cornall, Alyssa M., Tabrizi, Sepehr N., Morrow, Andrea, and Chen, Marcus Y.
- Abstract
Objectives To report on sexual behaviors and sexually transmitted infections (STIs) among men who have sex with men (MSM) in their teens, when many MSM engage in their first sexual experiences.Methods MSM aged 16 to 20 years were recruited via community and other sources. Men completed a questionnaire about their sexual behaviors and were screened for gonorrhea, chlamydia, syphilis, and HIV.Results Two hundred men were included. The median age was 19 years. The median age at first insertive or receptive anal intercourse was 17 years. Half of men reported sex with mainly older men: these men were more likely to engage in receptive anal intercourse (48% vs. 25%, p < .001) than other men. Most men had engaged in insertive (87%) and receptive (85%) anal intercourse in the prior 12 months with 60% and 53% reporting inconsistent condom use with insertive and receptive anal intercourse partners, respectively. The median number of insertive anal intercourse partners was 3 and 1.5 (p < .001) among men reporting inconsistent and consistent condom use with insertive anal intercourse over the prior 12 months. The median number of receptive anal intercourse partners was 3 and 2 (p = .006) among men reporting inconsistent and consistent condom use with receptive anal intercourse over the prior 12 months. Pharyngeal gonorrhea, rectal gonorrhea, urethral chlamydia, rectal chlamydia, and syphilis were detected in 3.0%, 5.5%, 3.0%, 4%, and 2.0% of men, respectively. All men were HIV negative.Conclusions Many of the teenage MSM in this study were at risk for STI. Preventative messages and STI screening interventions that are age appropriate need to be developed to reduce HIV and STI risk in this under-recognized group. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
15. How very young men who have sex with men view vaccination against human papillomavirus.
- Author
-
Zou, Huachun, Grulich, Andrew E., Cornall, Alyssa M., Tabrizi, Sepehr N., Garland, Suzanne M., Prestage, Garrett, Bradshaw, Catriona S., Hocking, Jane S., Morrow, Andrea, Fairley, Christopher K., and Chen, Marcus Y.
- Subjects
- *
HUMAN papillomavirus vaccines , *MEN who have sex with men , *SEXUAL intercourse , *ANAL cancer , *MEDICAL care costs , *PREVENTION ,PAPILLOMAVIRUS disease prevention - Abstract
Abstract: Background: HPV vaccination of men who have sex with men (MSM) prior to the commencement of sexual activity would have the maximum impact on preventing HPV and anal cancer in this population. However, knowledge and attitudes towards HPV vaccination among very young MSM have not been previously studied. Methods: Two hundred MSM aged 16 to 20 were recruited via community and other sources. Participants were asked about their knowledge and attitudes towards HPV and HPV vaccination. Results: Most (80%, 95% confidence interval (CI) 72.2–87.2%) men were not willing to purchase the vaccine because of its cost (AUD$450). However, if the vaccine was offered to MSM free of charge, 86% (95% CI: 80–90%) reported they would be willing to disclose their sexuality to a health care provider in order to obtain the vaccine. Over half (54%, 95%: 47–61%) of men would only be willing to disclose their sexuality to receive the HPV vaccine after their first experience of anal intercourse. The age at first insertive anal intercourse and the age at first receptive anal intercourse were 0.21 (IQR: −2.5 to 3.2) and 0.17 (IQR: −2.9 to 2.7) years earlier than the age that men would be willing to disclose their sexuality to receive the HPV vaccine, respectively. Willingness to receive the vaccine at a younger age was associated with younger age at first insertive anal intercourse. Conclusion: Overall, very young MSM expressed high acceptance of HPV vaccination. Early, opportunistic vaccination of very young MSM may be feasible in settings where very young MSM have not been vaccinated through universal programs targeting school aged males. However, given HPV infections occur early on, the effectiveness of this approach will be less than vaccination targeting school aged boys. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
16. Changes in human papillomavirus prevalence, incidence, and clearance among men who have sex with men in Xinjiang, China after implementation of nonpharmaceutical interventions to control COVID-19: An interrupted time series analysis.
- Author
-
Tian, Tian, Fu, Leiwen, Lu, Zhen, Wu, Xinsheng, Luo, Ganfeng, Wang, Bingyi, Zhou, Xinyi, Lin, Yi-Fan, Zhang, Zewen, Liu, Lirong, Xi, Miaomiao, Zhen, Chen, Dai, Jianghong, and Zou, Huachun
- Subjects
- *
HUMAN papillomavirus , *TIME series analysis , *COVID-19 pandemic , *GENITAL warts , *COVID-19 - Abstract
• We analyzed human papillomavirus (HPV) transmission among men who have sex with men (MSM) during the COVID-19 nonpharmaceutical interventions (NPIs). • HPV transmission among MSM changed during the implementation of COVID-19 NPIs. • The prevalence and incidence of HPV decreased during implementation of NPIs. • The clearance of HPV increased during implementation of NPIs. • The impact of COVID-19 NPIs on HPV may be due to disruption of sexual behavior. This study aimed to assess the effects of COVID-19 nonpharmaceutical interventions (NPIs) on the human papillomavirus (HPV) epidemic among men who have sex with men (MSM) in Xinjiang, China. In our cohort study, we enrolled and followed HIV-negative MSM in Xinjiang, China, between 2016 and 2022. Anal swab samples were collected to test for HPV DNA. We used interrupted time series analysis to characterize the temporal trends in HPV prevalence, incidence, and clearance before (September 01, 2016, to July 16, 2020) and during the implementation of COVID-19 NPIs in Xinjiang (July 17, 2020, to March 31, 2022). We used binomial segmented regression models to estimate the impact of COVID-19 NPIs on HPV prevalence, incidence, and clearance. We recruited 1296 MSM who contributed to a total of 5374 HPV tests in our study. COVID-19 NPIs were associated with a 37.9% decrease in the prevalence (prevalence ratio, 0.621; 95% confidence interval, 0.465-0.830), 52.2% decrease in the incidence (risk ratio, 0.478; 0.377-0.606), and 40.4% increase in the clearance (risk ratio, 1.404; 1.212-1.627) of HPV of any genotype after the implementation of COVID-19 NPIs in Xinjiang. COVID-19 NPIs may lead to lower transmission and higher clearance of HPV among MSM. Future studies are needed to clarify the longer-term impact of COVID-19 on the transmission and natural history of HPV among MSM. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework.
- Author
-
Nadarzynski, Tom, Frost, Miles, Miller, Danny, Wheldon, Christopher W., Wiernik, Brenton M., Zou, Huachun, Richardson, Daniel, Marlow, Laura A.V., Smith, Helen, Jones, Christina J., and Llewellyn, Carrie
- Subjects
- *
MEN who have sex with men , *META-analysis , *SEXUALLY transmitted diseases , *DECISION support systems , *HUMAN papillomavirus vaccines , *MEDICAL personnel , *VACCINES - Abstract
• Men who have sex with men are receptive to vaccines against sexually transmitted infections. • Vaccine uptake and completion may not reach levels as predicted in cost-effectiveness modelling. • Additional support, resources and investment are needed to reach optimal vaccination rates in MSM. Due to an increased risk of sexually transmitted infections (STIs), gay, bisexual and other men who have sex with men (MSM) have been recommended to receive vaccinations against human papillomavirus, meningitis C and hepatitis A/B. This review aimed to compare the rates of vaccine acceptability, uptake and completion, and to identify determinants of vaccine outcomes specific to MSM to inform a theoretical framework. In January 2020 four databases were explored to identify vaccination behaviours and associated factors among MSM. A narrative systematic review and meta -analysis were performed. Data were synthesised for theoretical modelling. Seventy-eight studies, mostly from the USA, were included. The average vaccine acceptability was 63% (median = 72%, range: 30%-97%), vaccine uptake 45% (median = 42%, range: 5%-100%) and vaccine completion 47% (median = 45%, range: 12%-89%). Six categories of factors associated with vaccination acceptability, uptake and completion were conceptualised: Individual (e.g., demographic and psychosocial); Interpersonal (e.g., peer education); Healthcare provider (e.g., vaccine recommendation); Organisational and practice setting (e.g., routine collection of patient sexual orientation information that is integrated into a clinical decision support system); Community environment (e.g., targeted health promotion campaigns); and National, state and local policy environment (e.g., public health guidelines targeting MSM). Despite overall high levels of acceptability, uptake and completion rates were below targets predicted by cost-effectiveness modelling across all recommended vaccines. These parameters may need to be adjusted for more precise estimations of cost-effectiveness. Addressing the multiple levels of determinants, as outlined in our theoretical framework, will help guide interventions to increase vaccine completion among MSM. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. Anal human papillomavirus among men who have sex with men in three metropolitan cities in southern China: implications for HPV vaccination.
- Author
-
Zhou, Yiguo, Lin, Yi-Fan, Meng, Xiaojun, Duan, Qibin, Wang, Zhenyu, Yang, Bin, Zheng, Heping, Li, Peiyang, Li, Meijuan, Lu, Yong, Luo, Zhenzhou, and Zou, Huachun
- Subjects
- *
PAPILLOMAVIRUSES , *HUMAN papillomavirus vaccines , *PAPILLOMAVIRUS diseases , *DRUG abuse , *SEXUALLY transmitted diseases , *HIV , *HIV infections - Abstract
Men who have sex with men (MSM), especially those infected with human immunodeficiency virus (HIV), are at disproportionate risk for human papillomavirus (HPV) infection. Data about anal HPV prevalence among MSM in southern China are limited. MSM were recruited between January 1 and August 31, 2017 in three metropolitan cities: Guangzhou, Shenzhen and Wuxi. A self-completed tablet-based questionnaire was used to collect information about socio-demographic/sexual behavioral characteristics, history of sexually transmitted infections (STIs) and recreational drug use. An anal brush was used to collect exfoliated cells for HPV DNA testing and genotyping, and a blood sample was taken for HIV testing. Penile/anal warts were checked by a clinician. A total of 536 MSM were enrolled, including 39 HIV-positive and 497 HIV-negative individuals. Compared with HIV-negative MSM, prevalence of any HPV genotype (79.5% vs 46.7%), any high-risk genotype (64.1% vs 36.6%) and any nonavalent vaccine-preventable genotype (53.9% vs 31.6%) was significantly higher in HIV-positive MSM, with all P < 0.01. HIV infection (adjusted odds ratio [AOR], 4.28; 95% confidence interval [CI], 1.87–9.80), using recreational drugs (AOR, 1.87; 95% CI, 1.22–2.87), having ≥ 3 years of sexual experience (AOR, 1.52; 95% CI, 1.01–2.28), having ≥ 6 lifetime male partners (AOR, 1.92; 95% CI, 1.29–2.86), and engaging receptive anal intercourse (AOR, 2.30; 95% CI, 1.48–3.57) were associated with higher anal HPV prevalence. Any HPV prevalence increased with age, from 24.5% at < 20 years to 55.8% at ≥ 40 years. Anal HPV prevalence was high among MSM in southern China, significantly associated with HIV status and sexual experience. HPV prevalence increased with age among MSM. A targeted HPV vaccination program for teenage MSM might be necessary. Our findings will inform targeted HPV modelling among MSM in China. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Targeted human papillomavirus vaccination for young men who have sex with men in Australia yields significant population benefits and is cost-effective.
- Author
-
Zhang, Lei, Regan, David G., Ong, Jason J., Gambhir, Manoj, Chow, Eric P.f., Zou, Huachun, Law, Matthew, Hocking, Jane, and Fairley, Christopher K.
- Subjects
- *
HUMAN papillomavirus vaccines , *MEN who have sex with men , *SEXUAL intercourse , *ANAL cancer , *CANCER risk factors , *WARTS , *STANDARDS , *MEDICAL care - Abstract
Background We investigated the effectiveness and cost-effectiveness of a targeted human papillomavirus (HPV) vaccination program for young (15–26) men who have sex with men (MSM). Methods We developed a compartmental model to project HPV epidemic trajectories in MSM for three vaccination scenarios: a boys program, a targeted program for young MSM only and the combination of the two over 2017–2036. We assessed the gain in quality-adjusted-life-years (QALY) in 190,000 Australian MSM. Results A targeted program for young MSM only that achieved 20% coverage per year, without a boys program, will prevent 49,283 (31,253–71,500) cases of anogenital warts, 191 (88–319) person-years living with anal cancer through 2017–2036 but will only stablise anal cancer incidence. In contrast, a boys program will prevent 82,056 (52,100–117,164) cases of anogenital warts, 447 (204–725) person-years living with anal cancers through 2017–2036 and see major declines in anal cancer. This can reduce 90% low- and high-risk HPV in young MSM by 2024 and 2032, respectively, but will require vaccinating ≥84% of boys. Adding a targeted program for young MSM to an existing boys program would prevent an additional 14,912 (8479–21,803) anogenital wart and 91 (42–152) person-years living with anal cancer. In combination with a boys’ program, a catch-up program for young MSM will cost an additional $AUD 6788 ($4628–11,989) per QALY gained, but delaying its implementation reduced its cost-effectiveness. Conclusions A boys program that achieved coverage of about 84% will result in a 90% reduction in HPV. A targeted program for young MSM is cost-effective if timely implemented. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
20. Acceptability of human papillomavirus vaccine among parents of junior middle school students in Jinan, China.
- Author
-
Wang, Wei, Ma, Yuanyuan, Wang, Xia, Zou, Huachun, Zhao, Fanghui, Wang, Shaoming, Zhang, Shaokai, Zhao, Yong, Marley, Gifty, and Ma, Wei
- Subjects
- *
HUMAN papillomavirus vaccines , *CROSS-sectional method , *MIDDLE school students , *PARENT attitudes , *CERVICAL cancer , *CANCER prevention - Abstract
Objective To determine the level of awareness on human papillomavirus (HPV) vaccine and acceptance of HPV vaccination among parents of junior middle school students. Methods A cross sectional survey employing cluster sampling was conducted in Jinan, Shandong Province of China in January of 2013. Results A total of 400 parents of junior middle school students participated in the questionnaire survey, among whom 360 (90%) completed valid questionnaires. About 88 (22.63%) parents had ever heard of HPV. Only one in ten (10.2%) knew about HPV vaccine. Parents willing to accept HPV vaccination for children accounted for 40.8%. Factors associated willing to accept HPV vaccination for children among parents were: female parent (AOR: 0.38, 95%CI: 0.21–0.67), having ever heard of HPV vaccine (AOR: 2.38, 95%CI: 1.01–5.61), thinking HPV vaccination should commence before sexual debut(AOR: 2.16, 95%CI: 1.21–3.85), thinking HPV vaccination should commence before 12 years old (AOR: 2.76, 95%CI: 1.02–7.46) or 13–15 years old (AOR: 4.75, 95%CI: 1.79–12.61), concern about suffering from cervical cancer and/or genital warts (AOR: 2.43, 95%CI: 1.31–4.50). About 60% of parents were in favor of future HPV vaccination promoting in China believing that HPV vaccine could efficiently prevent cervical cancer, anal cancer or genital warts, 37.4% of parents with expectation of governmental subsidy and price regulation. Conclusion Parental awareness level of HPV vaccine and willingness to accept HPV vaccination for children was low. However, the general attitude of many participants toward future promoting of HPV vaccination in China was encouraging, particularly if certain expectations were met. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. Is ceftriaxone similarly effective to benzylpenicillin in neurosyphilis?
- Author
-
Ke, Wujian, Fu, Leiwen, Wang, Bingyi, Leng, Xinying, and Zou, Huachun
- Subjects
- *
NEUROSYPHILIS , *PENICILLIN G , *CEFTRIAXONE - Published
- 2021
- Full Text
- View/download PDF
22. A research agenda for ageing in China in the 21st century (2nd edition): Focusing on basic and translational research, long-term care, policy and social networks.
- Author
-
Fang, Evandro F., Xie, Chenglong, Schenkel, Joseph A., Wu, Chenkai, Long, Qian, Cui, Honghua, Aman, Yahyah, Frank, Johannes, Liao, Jing, Zou, Huachun, Wang, Ninie Y., Wu, Jing, Liu, Xiaoting, Li, Tao, Fang, Yuan, Niu, Zhangming, Yang, Guang, Hong, Jiangshui, Wang, Qian, and Chen, Guobing
- Subjects
- *
LONG-term health care , *HOME care services , *SOCIAL networks , *OLDER people , *HEALTH literacy , *TRANSLATIONAL research , *FRAIL elderly , *BIRD nests - Abstract
• Covered broad fields of ageing in China: statistics, basic and translational research, long-term care, policy and social networks. • Provided more detailed numerical updates of the ageing challenges in China. • New features of the aging-related challenges, e.g., oral ageing and STDs in the elderly in China. • A new and independent section on immune ageing. • We also mentioned the COVID-19-induced death in the Chinese elderly. One of the key issues facing public healthcare is the global trend of an increasingly ageing society which continues to present policy makers and caregivers with formidable healthcare and socio-economic challenges. Ageing is the primary contributor to a broad spectrum of chronic disorders all associated with a lower quality of life in the elderly. In 2019, the Chinese population constituted 18 % of the world population, with 164.5 million Chinese citizens aged 65 and above (65+), and 26 million aged 80 or above (80+). China has become an ageing society, and as it continues to age it will continue to exacerbate the burden borne by current family and public healthcare systems. Major healthcare challenges involved with caring for the elderly in China include the management of chronic non-communicable diseases (CNCDs), physical frailty, neurodegenerative diseases, cardiovascular diseases, with emerging challenges such as providing sufficient dental care, combating the rising prevalence of sexually transmitted diseases among nursing home communities, providing support for increased incidences of immune diseases, and the growing necessity to provide palliative care for the elderly. At the governmental level, it is necessary to make long-term strategic plans to respond to the pressures of an ageing society, especially to establish a nationwide, affordable, annual health check system to facilitate early diagnosis and provide access to affordable treatments. China has begun work on several activities to address these issues including the recent completion of the of the Ten-year Health-Care Reform project, the implementation of the Healthy China 2030 Action Plan, and the opening of the National Clinical Research Center for Geriatric Disorders. There are also societal challenges, namely the shift from an extended family system in which the younger provide home care for their elderly family members, to the current trend in which young people are increasingly migrating towards major cities for work, increasing reliance on nursing homes to compensate, especially following the outcomes of the 'one child policy' and the 'empty-nest elderly' phenomenon. At the individual level, it is important to provide avenues for people to seek and improve their own knowledge of health and disease, to encourage them to seek medical check-ups to prevent/manage illness, and to find ways to promote modifiable health-related behaviors (social activity, exercise, healthy diets, reasonable diet supplements) to enable healthier, happier, longer, and more productive lives in the elderly. Finally, at the technological or treatment level, there is a focus on modern technologies to counteract the negative effects of ageing. Researchers are striving to produce drugs that can mimic the effects of 'exercising more, eating less', while other anti-ageing molecules from molecular gerontologists could help to improve 'healthspan' in the elderly. Machine learning, 'Big Data', and other novel technologies can also be used to monitor disease patterns at the population level and may be used to inform policy design in the future. Collectively, synergies across disciplines on policies, geriatric care, drug development, personal awareness, the use of big data, machine learning and personalized medicine will transform China into a country that enables the most for its elderly, maximizing and celebrating their longevity in the coming decades. This is the 2nd edition of the review paper (Fang EF et al., Ageing Re. Rev. 2015). [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.